Scilex Holding Company Payments for Repurchase of Warrants
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Scilex Holding Company payments for repurchase of warrants for the quarter ending 2025-12-31 was $14.00M.
- Scilex Holding Company payments for repurchase of warrants for the quarter ending 2024-12-31 was -$300.00K.
- Scilex Holding Company payments for repurchase of warrants for the quarter ending 2024-09-30 was $298.00K.
- Scilex Holding Company payments for repurchase of warrants for the quarter ending 2023-12-31 was $0.00.
- Scilex Holding Company payments for repurchase of warrants for fiscal 2025 was $27.00M.
- Scilex Holding Company payments for repurchase of warrants for fiscal 2024 was $0.00.
- Scilex Holding Company payments for repurchase of warrants for fiscal 2023 was $0.00.
| Period end | Payments for Repurchase of Warrants 3 month | Payments for Repurchase of Warrants 12 month |
|---|---|---|
| 2025-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $27.00M 10-K · filed 2026-04-10 |
| 2024-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $0.00 10-K · filed 2026-04-10 |
| 2024-09-30 | $298.00K 10-Q · filed 2025-01-17 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |